These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31797632)

  • 1. PGxMine: Text mining for curation of PharmGKB.
    Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
    Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation-centric approach to identifying pharmacogenomic relations in text.
    Rance B; Doughty E; Demner-Fushman D; Kann MG; Bodenreider O
    J Biomed Inform; 2012 Oct; 45(5):835-41. PubMed ID: 22683993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards pathway curation through literature mining--a case study using PharmGKB.
    Ravikumar KE; Wagholikar KB; Liu H
    Pac Symp Biocomput; 2014; ():352-63. PubMed ID: 24297561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using PharmGKB to train text mining approaches for identifying potential gene targets for pharmacogenomic studies.
    Pakhomov S; McInnes BT; Lamba J; Liu Y; Melton GB; Ghodke Y; Bhise N; Lamba V; Birnbaum AK
    J Biomed Inform; 2012 Oct; 45(5):862-9. PubMed ID: 22564551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the BioCreative VI Precision Medicine Track: mining protein interactions and mutations for precision medicine.
    Islamaj Dogan R; Kim S; Chatr-Aryamontri A; Wei CH; Comeau DC; Antunes R; Matos S; Chen Q; Elangovan A; Panyam NC; Verspoor K; Liu H; Wang Y; Liu Z; Altinel B; Hüsünbeyi ZM; Özgür A; Fergadis A; Wang CK; Dai HJ; Tran T; Kavuluru R; Luo L; Steppi A; Zhang J; Qu J; Lu Z
    Database (Oxford); 2019 Jan; 2019():. PubMed ID: 30689846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
    Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. tmVar 2.0: integrating genomic variant information from literature with dbSNP and ClinVar for precision medicine.
    Wei CH; Phan L; Feltz J; Maiti R; Hefferon T; Lu Z
    Bioinformatics; 2018 Jan; 34(1):80-87. PubMed ID: 28968638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PharmGKB: A worldwide resource for pharmacogenomic information.
    Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
    Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A SNPshot of PubMed to associate genetic variants with drugs, diseases, and adverse reactions.
    Hakenberg J; Voronov D; Nguyên VH; Liang S; Anwar S; Lumpkin B; Leaman R; Tari L; Baral C
    J Biomed Inform; 2012 Oct; 45(5):842-50. PubMed ID: 22564364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource.
    McDonagh EM; Whirl-Carrillo M; Garten Y; Altman RB; Klein TE
    Biomark Med; 2011 Dec; 5(6):795-806. PubMed ID: 22103613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge.
    Hernandez-Boussard T; Whirl-Carrillo M; Hebert JM; Gong L; Owen R; Gong M; Gor W; Liu F; Truong C; Whaley R; Woon M; Zhou T; Altman RB; Klein TE
    Nucleic Acids Res; 2008 Jan; 36(Database issue):D913-8. PubMed ID: 18032438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
    Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
    Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.
    Lever J; Jones MR; Danos AM; Krysiak K; Bonakdar M; Grewal JK; Culibrk L; Griffith OL; Griffith M; Jones SJM
    Genome Med; 2019 Dec; 11(1):78. PubMed ID: 31796060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.